Premium
Risk/benefit ratios in the management of gynecologic cancer
Author(s) -
Morris John Mclean
Publication year - 1981
Publication title -
cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.052
H-Index - 304
eISSN - 1097-0142
pISSN - 0008-543X
DOI - 10.1002/1097-0142(19810715)48:1+<642::aid-cncr2820481332>3.0.co;2-f
Subject(s) - medicine , gynecologic cancer , cancer , gynecology , obstetrics , general surgery , intensive care medicine , ovarian cancer
While earlier diagnosis and better treatment have produced improved results in gynecologic cancer, diagnostic techniques and therapeutic regimens should be evaluated not just by tumor remissions or five‐year cures but also by whether simpler methods might be equally effective, at lower cost, with less disability, with a shorter hospital stay, and with less disturbance to the patient and her family. The objectives of treatment should be to achieve the maximum in tumor cure with the lowest level of complications. Because of deaths from injuries related to overtreatment, less invasive and less toxic therapy may at times prove more effective than more radical treatment.